Suspended

Brain Imaging and Development Trajectories in Childhood Onset Psychiatric and Endocrine Disorders

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
Study Aim

This study aims to observe and understand the development trajectories in children with psychiatric and endocrine disorders by using brain imaging techniques such as volumetric MRI.

What is being collected

Data Collection

Collected from today forward - Prospective
Who is being recruted

Mental Disorders+11

+ Central Nervous System Diseases

+ Movement Disorders

From 3 to 120 Years
1 Eligibility Criteria
See all eligibility criteria
How is the trial designed

Cohort

Tracking disease incidence in order to identify risk factors and understand disease progression over time.
Observational
Study Start: June 1990
See protocol details

Summary

Principal SponsorNational Institute of Mental Health (NIMH)
Last updated: October 2, 2026
Sourced from a government-validated database.Claim as a partner

Study start date: June 19, 1990

Actual date on which the first participant was enrolled.

Study Description: This natural history protocol will have participants come to the NIH for brain imaging, psychological/psychiatric testing, and genetic characterization. Our core hypotheses are that many of the most severe neuropsychiatric disorders of childhood onset are associated with deviations from the path of normal brain development, the neuroanatomical substrates of which can be detected by magnetic resonance imaging. Objectives: Primary Objectives: The long-term objectives of the protocol are to (1) map the neuroanatomic and neurophysiological trajectories of brain development; and (2) discern the influences, for good or ill, on those trajectories from demographic clinical, genetic, and environmental factors. Approximately half of the participants in our sample are typically developing. Clinical populations in our sample include participants with a variety of brain-based disorders, such as Autism, Attention-Deficit/Hyperactivity Disorder, Childhood Onset Schizophrenia, Dyslexia, Sydenham s Chorea, and Tourette s Syndrome. Secondary Objectives: To characterize the relationships among measures of behavior and cognition as well as amongst multimodal measures of brain organization. Endpoints: Primary Endpoint: T1-weighted structural neuroimaging data which enable us to characterize how a range of anatomical brain phenotypes vary as a function of age, sex, behavioral/cognitive traits, diagnostic status and genotype. Secondary Endpoints: Data analyses also consider how these factors relate to other outcomes of interest including; gene expression levels, functional metrics from in vivo neuroimaging, and questionnaire/interview-based assessment of clinical features.

NCT00001246
Principal SponsorNational Institute of Mental Health (NIMH)
Last updated: October 2, 2026
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

4274 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Cohort

These studies follow a group of individuals with common characteristics (such as a condition or birth year) over a specific period to study health outcomes or exposures.

Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions
Criteria

Any sex

Biological sex of participants that are eligible to enroll.

From 3 to 120 Years

Range of ages for which participants are eligible to join.

Healthy volunteers allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

Mental DisordersCentral Nervous System DiseasesMovement DisordersNervous System DiseasesNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsAttention Deficit and Disruptive Behavior DisordersSchizophrenia Spectrum and Other Psychotic DisordersDyskinesiasNeurodevelopmental DisordersAttention Deficit Disorder with HyperactivityChoreaSchizophrenia

Criteria

1 inclusion criteria required to participate
Participants consenting to participation in the study

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.
Treatment Groups
Study Objectives

One single intervention group is designated in this study

This study does not include a placebo group 

Treatment Groups

Study Objectives

Primary Objectives

Secondary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 1 location

National Institutes of Health Clinical Center

Bethesda, United StatesOpen National Institutes of Health Clinical Center in Google Maps
SuspendedOne Study Center